1.1267
price down icon2.63%   -0.0133
 
loading
전일 마감가:
$1.14
열려 있는:
$1.07
하루 거래량:
395
Relative Volume:
0.04
시가총액:
$13.61M
수익:
$3.37M
순이익/손실:
$-57.28M
주가수익비율:
-0.1048
EPS:
-10.7522
순현금흐름:
$-51.83M
1주 성능:
-4.64%
1개월 성능:
-7.50%
6개월 성능:
-23.97%
1년 성능:
-40.96%
1일 변동 폭
Value
$1.07
$1.07
1주일 범위
Value
$1.05
$1.20
52주 변동 폭
Value
$0.898
$1.91

신로직 Stock (SYBX) Company Profile

Name
명칭
Synlogic Inc
Name
전화
617-659-2802
Name
주소
PO BOX 30, WINCHESTER, MA
Name
직원
1
Name
트위터
@synlogic_tx
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
SYBX's Discussions on Twitter

SYBX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SYBX
Synlogic Inc
1.07 13.61M 3.37M -57.28M -51.83M -10.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
500.54 126.96B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
607.42 65.06B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
648.27 37.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
259.44 32.56B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
255.35 26.40B 3.81B -644.79M -669.77M -6.24

신로직 Stock (SYBX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-11-24 업그레이드 Oppenheimer Perform → Outperform
2019-08-21 다운그레이드 Oppenheimer Outperform → Perform
2019-04-30 개시 Jefferies Buy
2018-12-13 개시 Chardan Capital Markets Buy
2018-03-19 개시 H.C. Wainwright Buy
2018-01-29 개시 Piper Jaffray Overweight
모두보기

신로직 주식(SYBX)의 최신 뉴스

pulisher
Apr 03, 2025

Synlogic’s executive Mary Beth Dooley sells $172 in common stock - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Synlogic’s executive Mary Beth Dooley sells $172 in common stock By Investing.com - Investing.com UK

Apr 03, 2025
pulisher
Apr 03, 2025

SYBX stock touches 52-week low at $1.14 amid market challenges - Investing.com India

Apr 03, 2025
pulisher
Apr 02, 2025

5 Best Microbiome Companies (May 2025) - Securities.io

Apr 02, 2025
pulisher
Mar 24, 2025

Gallium Arsenide Market Applications and Semiconductor Industry Impact - openPR.com

Mar 24, 2025
pulisher
Mar 19, 2025

Synlogic (NASDAQ:SYBX) Shares Pass Below Fifty Day Moving Average – Here’s Why - Defense World

Mar 19, 2025
pulisher
Mar 11, 2025

SYBX stock touches 52-week low at $1.15 amid market challenges - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

Synlogic (SYBX) to Release Quarterly Earnings on Tuesday - Defense World

Mar 11, 2025
pulisher
Mar 06, 2025

Synlogic Inc. (SYBX) reports earnings - Quartz

Mar 06, 2025
pulisher
Feb 21, 2025

Week Ahead (Nov.2226): FDA Decision, Data Presentations (ABEO, SYBX, AADI…) - RTTNews

Feb 21, 2025
pulisher
Feb 06, 2025

CRISPR and Cas Gene Market May Set a New Epic Growth Story | Fate Therapeutics, Cellectis, Synlogic - Newstrail

Feb 06, 2025
pulisher
Feb 06, 2025

Microbiomes Market to Grow by USD 824.3 Million (2025-2029) with Rising Disease Prevalence Boosting the Market, Report on How AI is Redefining Market LandscapeTechnavio - The Malaysian Reserve

Feb 06, 2025
pulisher
Feb 05, 2025

Synlogic's executive sells shares worth $2,802 - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

Synlogic's executive sells shares worth $2,802 By Investing.com - Investing.com South Africa

Feb 05, 2025
pulisher
Feb 04, 2025

Promising Growth Expected in Gout Therapeutics Market, Set to Reach $5.03 Billion by 2029 with a CAGR of 11.7% - WhaTech

Feb 04, 2025
pulisher
Jan 23, 2025

Synlogic (SYBX) Stock Price, News & Analysis - MarketBeat

Jan 23, 2025
pulisher
Jan 14, 2025

Synlogic announces board member resignation By Investing.com - Investing.com Canada

Jan 14, 2025
pulisher
Jan 14, 2025

Synlogic announces board member resignation - Investing.com

Jan 14, 2025
pulisher
Dec 27, 2024

The definitive Boston biotech layoff tracker for 2024 - The Business Journals

Dec 27, 2024
pulisher
Dec 21, 2024

Fmr LLC Trims Stock Holdings in Synlogic, Inc. (NASDAQ:SYBX) - Defense World

Dec 21, 2024
pulisher
Dec 21, 2024

Biopolymers Market to Reach USD 47.4 Billion by 2032 Driven - GlobeNewswire

Dec 21, 2024
pulisher
Dec 13, 2024

Synlogic (NASDAQ:SYBX) Trading Down 0.7% – What’s Next? - Defense World

Dec 13, 2024
pulisher
Dec 13, 2024

Only the paranoid survive, and the CEO’s paradox, from Aoife Brennan - BioCentury

Dec 13, 2024
pulisher
Dec 03, 2024

Urea Cycle Disorder Treatment Market to Grow by USD 215.4 Million (2024-2028), Driven by Rising Prevalence, with AI Redefining Market LandscapeTechnavio - The Malaysian Reserve

Dec 03, 2024
pulisher
Nov 30, 2024

Synlogic (FRA:MIN) 3-Year FCF Growth Rate : 21.90% (As of Sep. 2024) - GuruFocus.com

Nov 30, 2024
pulisher
Nov 30, 2024

Synlogic (FRA:MIN) Momentum Rank : 2 (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024
pulisher
Nov 20, 2024

Phenylketonuria Market size is ~700 USD million in 2023, asserts DelveInsight | Pharma Giants: PTC Therapeutics, Homology Medicines, Synlogic, BioMarin Pharmaceuticals - The Globe and Mail

Nov 20, 2024
pulisher
Nov 19, 2024

Microbiomes Market to Grow by USD 1.13 Billion (2024-2028), Rising Disease Prevalence Driving Revenue, with AI Powering Market EvolutionTechnavio - The Malaysian Reserve

Nov 19, 2024
pulisher
Nov 15, 2024

Synlogic Third Quarter 2024 Earnings: US$0.01 loss per share (vs US$2.57 loss in 3Q 2023) - Yahoo Finance

Nov 15, 2024
pulisher
Nov 13, 2024

Synlogic Reports Q3 2024 Financial Outcomes - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

Synlogic Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Synlogic (SYBX) Slashes Q3 Losses by 99% Amid Strategic Review, No Revenue | SYBX Stock News - StockTitan

Nov 12, 2024
pulisher
Oct 31, 2024

The 2024 Biotech Graveyard - Fierce Biotech

Oct 31, 2024
pulisher
Oct 30, 2024

Synlogic's head of finance Mary Beth Dooley sells $110 in stock - Investing.com

Oct 30, 2024
pulisher
Oct 22, 2024

(PDF) The effects of caffeinated and decaffeinated coffee on sex hormone-binding globulin and endogenous sex hormone levels: A randomized controlled trial - ResearchGate

Oct 22, 2024
pulisher
Oct 18, 2024

Oxygen Scavenger Market Set to Reach USD 8.2 Billion by - GlobeNewswire

Oct 18, 2024
pulisher
Oct 17, 2024

Synlogic says co entered into sales agreement with Cowen And Company, LLC ​ - Reuters

Oct 17, 2024
pulisher
Sep 26, 2024

Urea Cycle Disorders Treatment Market Research In New Report - WhaTech

Sep 26, 2024
pulisher
Aug 08, 2024

Synlogic Reports Second Quarter 2024 Financial Results - GlobeNewswire

Aug 08, 2024
pulisher
Aug 01, 2024

Otsuka snaps up Jnana with its phenylketonuria drug for $800m - Pharmaceutical Technology

Aug 01, 2024
pulisher
Jun 13, 2024

Xilio Therapeutics Appoints Aoife Brennan and James Shannon to its Board of Directors - citybiz

Jun 13, 2024
pulisher
May 29, 2024

Gut Microbiota Market Set to Reach a Staggering US$ 3,600.1 Million by 2032 - BioSpace

May 29, 2024
pulisher
May 14, 2024

Synlogic Reports First Quarter 2024 Financial Results - GlobeNewswire

May 14, 2024
pulisher
May 02, 2024

Designer Genes: Synlogic Is Crafting Living Therapeutics Programmed to Treat Disease: - Mary Ann Liebert, Inc.

May 02, 2024
pulisher
Apr 19, 2024

Human Microbiome Market Size & Share to Surpass USD 2,555 million by 2030 - WhaTech

Apr 19, 2024
pulisher
Mar 21, 2024

Synlogic Appoints James Flynn to Board Amidst Director Resignations - TipRanks

Mar 21, 2024
pulisher
Mar 19, 2024

Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewswire

Mar 19, 2024
pulisher
Feb 22, 2024

Synlogic Announces Top Executive Departures and Compensation Deals - TipRanks

Feb 22, 2024
pulisher
Feb 12, 2024

Irish-led Synlogic to cease operations after ending drug trial - Silicon Republic

Feb 12, 2024
pulisher
Feb 10, 2024

Synlogic Announces Plan to Cease Operations and Reduce Its Workforce by More Than 90% - SynBioBeta

Feb 10, 2024
pulisher
Feb 09, 2024

Synlogic shares downgraded to sell by H.C. Wainwright - Investing.com India

Feb 09, 2024

신로직 (SYBX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

신로직 주식 (SYBX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Dooley Mary Beth
See Remarks below
Feb 03 '25
Sale
1.33
2,107
2,802
13,045
Dooley Mary Beth
Head of Finance
Oct 29 '24
Sale
1.40
79
111
15,152
$72.51
price down icon 0.01%
$21.58
price up icon 2.96%
$32.56
price up icon 0.06%
$29.24
price up icon 18.78%
$105.61
price up icon 3.06%
biotechnology ONC
$256.40
price up icon 0.63%
자본화:     |  볼륨(24시간):